Types of stem cells illustration

Which Stem Cells Are Right for Therapy?

Learn how different stem cell types — from mesenchymal stem cells (MSCs) to autologous and allogeneic sources — are used in regenerative treatments. We explain benefits, typical applications, and how Viezec selects the safest, most effective option for each patient.

  • Overview of common therapeutic stem cell types
  • When autologous vs. allogeneic is recommended
  • Safety, sourcing, and clinical considerations


Book a Consultation

Trusted by 500+ patients from 20+ countries — personalized stem cell plans based on clinical evidence.

Types of Stem Cells Used in Therapy

Stem cell therapy can involve different sources depending on the patient’s condition, safety factors,
and treatment goals. Below are the most commonly used stem cell types in regenerative medicine.

Autologous Stem Cells

Collected from the patient’s own body, usually bone marrow or fat tissue.
Since these are self-derived, the risk of immune rejection is minimal.
They are effective for orthopedic, neurological, and autoimmune conditions.

Allogeneic Stem Cells

Derived from a healthy donor, these cells are processed to ensure safety and compatibility.
They are used when the patient’s own cells are not viable.
Applications include immune-related and degenerative disorders.

Mesenchymal Stem Cells (MSCs)

Multipotent cells that can be obtained from bone marrow, adipose tissue, or umbilical cords.
Known for repairing tissues, reducing inflammation, and promoting healing.
Widely studied for arthritis, spinal injuries, liver diseases, and more.

Induced Pluripotent Stem Cells (iPSCs)

Created by reprogramming adult cells into a stem cell–like state.
They can potentially differentiate into almost any cell type.
Still under research, they represent the future of personalized regenerative medicine.

How to Choose the Right Stem Cell Type for Therapy

Selecting the correct type of stem cell is crucial for achieving safe and effective results.
Factors such as the nature of the medical condition, patient health, cell compatibility, and
clinical evidence all play an important role in this decision. At Viezec, our specialists
personalize each recommendation to ensure the best possible outcomes.

  • Nature of the Condition: Neurological, orthopedic, autoimmune, or degenerative disorders.
  • Patient’s Own Cells vs. Donor Cells: When autologous stem cells are sufficient, or when allogeneic sources are needed.
  • Safety & Compatibility: Ensuring reduced risk of rejection and safe long-term use.
  • Availability of Sources: Options like bone marrow, adipose tissue, umbilical cord, or advanced iPSCs.
  • Clinical Evidence: Backed by ongoing research and successful patient outcomes worldwide.

Personalized Treatment Plan — Step-by-Step Process

At Viezec we follow a structured, evidence-based process to determine the right stem cell approach for each patient. Below is the typical pathway — from first consultation through long-term follow-up — highlighting what you can expect and why each step matters.

1. Initial Consultation

A specialist reviews your medical history, current symptoms, and prior treatments. This conversation helps us understand your goals and whether stem cell therapy is potentially appropriate.

Book a consult or request medical records for pre-evaluation.

2. Clinical Assessment & Diagnostics

We order targeted tests (imaging, bloodwork, functional scales) to objectively measure the condition and rule out contraindications. Results guide cell source selection and treatment intensity.

Typical tests: MRI/X-ray (for orthopedics), EMG/NCS (for nerve issues), autoantibody panels (for immune disorders).

3. Personalized Treatment Plan

Our multidisciplinary team synthesizes clinical data to recommend: the stem cell type (autologous/allogeneic/MSCs/iPSCs), delivery route (injection, IV, intrathecal), number of sessions, and adjunct therapies.

We also discuss expected benefits, realistic timelines, risks, and alternative options so you can give informed consent.

4. Cell Collection & Processing

If autologous, stem cells are harvested (e.g., bone marrow aspiration, adipose lipoaspirate). If allogeneic, donor units are sourced from certified banks and undergo rigorous screening and standardized processing.

Processing is performed under GMP-like conditions with sterility checks and potency verification before release for use.

5. Administration of Therapy

Cells are delivered using the method best suited to the condition — for example intra-articular injections for joints, intrathecal or epidural injection for spinal cord applications, or intravenous infusion for systemic conditions.

Procedures are performed by experienced clinicians with imaging guidance when required to ensure accuracy and patient comfort.

6. Post-Treatment Care & Rehabilitation

Recovery protocols and rehabilitation are personalized — physiotherapy, activity modification, and supportive medications (if needed) help maximize therapy benefits and functional recovery.

We provide clear aftercare instructions and a schedule for incremental progress checks.

7. Follow-up & Long-term Monitoring

Scheduled follow-ups assess clinical improvement with objective measures and ensure safety. We monitor for both short-term adverse events and long-term outcomes to refine future care.

Outcome metrics and imaging at 3, 6 and 12 months (or as clinically indicated) help determine success and next steps.


Speak With Our Specialists

Not sure which step applies to you? Book a free assessment to let our team evaluate your case.

Safety, Risks & Contraindications

Patient safety is our top priority. While stem cell therapy offers promising benefits, it is a medical procedure that carries potential risks and contraindications.
This section explains how Viezec minimizes risks through strict protocols, patient selection, and ongoing monitoring.

Our multidisciplinary team evaluates each candidate thoroughly to determine whether stem cell therapy is appropriate. We follow internationally recognized standards for donor screening,
cell processing, sterility, and potency testing. Informed consent is obtained after discussing realistic expectations, benefits, and possible adverse effects.

Below are the most important safety considerations — click any item to expand into detailed guidance or link to a full subpage.

Quick Safety Facts

  • All donor cells screened for infections and genetic safety.
  • Processing performed under controlled, sterile conditions.
  • Short-term side effects: mild pain, fever, local swelling.
  • Long-term monitoring recommended at 3, 6 and 12 months.

  • Potential Adverse Effects

    Transient pain, inflammation, fever, and rare allergic reactions. Serious complications are uncommon when proper protocols are followed.

  • Contraindications

    Active infections, uncontrolled malignancy, certain autoimmune flares, or conditions with high anesthetic risk may preclude treatment.

  • Donor Screening & Traceability

    Allogeneic cells are traceable to certified donor records, with rigorous infectious disease testing and documentation for audit trails.

  • Quality Control & Regulatory Compliance

    Cell handling follows GMP-like procedures, sterility testing, and potency assays to meet national and international safety expectations.

Post-Treatment Care & Follow-Up

The journey doesn’t end after the procedure. At Viezec, we provide structured post-treatment care to ensure smooth recovery,
track outcomes, and support patients in maximizing the benefits of stem cell therapy.

What to Expect After Treatment

Most patients experience mild fatigue, localized soreness, or temporary swelling at the injection/infusion site. These usually
resolve within a few days. Our care team remains available to guide you through any concerns during this period.

Recovery Guidelines

  • Avoid strenuous activity or heavy lifting for the first 7–10 days.
  • Maintain a balanced diet, hydration, and prescribed supplements.
  • Follow any physical therapy or rehabilitation exercises advised.
  • Monitor for signs of infection or unusual reactions and report immediately.

Structured Follow-Up Schedule

To track your progress and ensure lasting results, we provide a structured follow-up plan:

  • Week 1: Tele-consultation to address early recovery concerns.
  • Month 1: Physical evaluation and response monitoring.
  • Month 3: Imaging/lab tests to track regeneration progress.
  • Month 6: Mid-term outcome evaluation with progress reports.
  • Month 12: Comprehensive annual follow-up and future planning.

Expected Outcomes & Success Rates

Stem cell therapy is a breakthrough approach in regenerative medicine, but outcomes can vary depending on
the patient’s condition, age, lifestyle, and adherence to post-treatment care. At Viezec, we emphasize
setting realistic expectations while striving to deliver the highest possible success rates backed by
clinical evidence and global standards.

Symptom Improvement

Many patients report reduction in chronic pain, improved mobility, and better quality of life
within weeks to months of treatment. Neurological and autoimmune conditions may require longer
timelines for noticeable results.

Success Rates

Clinical studies and our own patient database show encouraging success rates ranging between
70%–90% depending on the condition treated. Outcomes are highest when patients
follow prescribed care plans and rehabilitation programs.

Long-Term Benefits

With regular monitoring and lifestyle adjustments, patients may sustain benefits for years.
Some require maintenance therapies, while others achieve lasting improvements with a single
treatment cycle.

Note: Individual results may vary. Viezec ensures transparency by sharing realistic expectations
based on each patient’s unique case history and global medical evidence.

Why Choose Viezec for Stem Cell Therapy

With years of expertise and a patient-first philosophy, Viezec stands as one of India’s
most trusted providers of regenerative medicine. Our integrated approach ensures safety,
transparency, and effective outcomes for every patient who chooses us for their stem cell therapy journey.

Expert Team

Expert Medical Team

Our highly qualified doctors, scientists, and support staff bring years of specialized
experience in stem cell research and clinical application.

Safety Standards

Global Safety Standards

We follow strict international protocols for cell collection, processing, and delivery
to ensure maximum safety and minimal risk for our patients.

Patient Care

Patient-Centered Care

From the first consultation to post-treatment follow-up, we prioritize your comfort,
well-being, and long-term recovery goals.

Proven Results

Proven Patient Outcomes

Trusted by 500+ patients across 20+ countries, our track record demonstrates high success
rates and sustainable improvements in quality of life.

Choosing Viezec means choosing expertise, trust, and personalized care for your stem cell journey.


Consult Our Specialists

Patient Stories & Testimonials

Real patients, real outcomes. Read first-hand experiences from people who chose Viezec for their stem cell therapy journey. Patient privacy is respected — some names and images are used with consent.

500+
Patients Treated
20+
Countries Served
4.6/5
Average Patient Rating

Rahul S.
New Delhi, India — Knee OA

“After two intra-articular MSC injections I experienced significant pain relief and regained mobility.
The team at Viezec guided me through every step — from tests to rehab.”

Maria G.
UK — Autoimmune Support

“My fatigue reduced and lab markers improved after the recommended protocol. Clear communication and attentive follow-up made a big difference.”

Ahmed K.
UAE — Spinal Injury

“Significant functional gains over 6 months. Frequent check-ins and objective measures kept us confident in progress.”

Featured Story: From Chronic Pain to Active Life — Meera’s Journey

Meera, a 54-year-old teacher, struggled with chronic knee pain for 8 years. Conservative treatments provided only temporary relief.
After a detailed assessment, Viezec recommended autologous MSC therapy combined with a tailored physiotherapy plan.
Within 3 months she reported 60% pain reduction and after 6 months returned to light jogging and daily activities with minimal discomfort.

Treatment: Autologous adipose-derived MSC injections + 12-week rehab program.
Outcomes: Reduced pain, improved range of motion, sustained functional improvement at 12 months.

Frequently Asked Questions

Here are answers to common questions about stem cell therapy at Viezec. Our goal is to help you make an informed decision with clarity and confidence.

What types of stem cells do you use for therapy?

We use both autologous (from the patient) and allogeneic (donor) mesenchymal stem cells derived from bone marrow or adipose tissue. The choice depends on your condition, age, and clinical assessment.

Is stem cell therapy safe?

Yes. Safety is our top priority. All procedures are performed under sterile conditions by trained clinicians, and donor cells undergo strict screening. Minor side effects such as mild swelling or fatigue may occur, but serious complications are rare.

How long does it take to see results?

Results vary depending on the condition treated. Many patients notice improvements in 4–12 weeks, while others, especially neurological or autoimmune cases, may require several months to observe significant changes.

Are multiple sessions required?

The number of sessions depends on your specific condition and response to therapy. During the personalized treatment planning, our team recommends the optimal protocol for your case.

Do you provide follow-up care?

Absolutely. We provide structured post-treatment follow-up including tele-consultations, lab tests, and clinical assessments to ensure safety, monitor progress, and maximize therapy benefits.

Ready to Begin Your Stem Cell Therapy Journey?

Take the first step toward better health and improved quality of life. Our expert team at Viezec is here to guide you through a safe, personalized, and effective stem cell treatment plan.



Schedule a Consultation

Trusted by 500+ patients from 20+ countries

Menu